GSK (GSK) News Today $38.65 +0.08 (+0.21%) Closing price 03:58 PM EasternExtended Trading$38.60 -0.05 (-0.14%) As of 05:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period GSK Enhances Shareholder Value with Continued Share BuybackMarch 25 at 4:49 PM | tipranks.comUS FDA greenlights GSK's drug for UTIs in women and girlsMarch 25 at 3:47 PM | msn.comUS FDA approves GSK's urinary tract infection drugMarch 25 at 12:00 PM | reuters.comGSK plc. (GSK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitMarch 25 at 12:00 PM | prnewswire.comEMA to review GSK’s Nucala for COPD treatment expansionMarch 25 at 10:46 AM | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming Deadlines - GSKMarch 25 at 10:00 AM | prnewswire.comGSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law FirmMarch 25 at 9:35 AM | prnewswire.comVirtu Financial LLC Decreases Stock Holdings in GSK plc (NYSE:GSK)Virtu Financial LLC cut its stake in GSK plc (NYSE:GSK - Free Report) by 31.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 20,272 shares of the pharmaceutical company's stock after selling 9,270March 25 at 4:31 AM | marketbeat.comGSK studying if best-selling shingles vaccine lowers dementia riskMarch 25 at 4:28 AM | reuters.comShould I buy GSK shares at £15?March 24 at 3:51 PM | msn.comGSK application to expand use of Nucala to COPD accepted for review by EMAMarch 24 at 3:51 PM | markets.businessinsider.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in GSK Lawsuit – GSKMarch 24 at 2:26 PM | globenewswire.comROSEN, SKILLED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSKMarch 24 at 1:59 PM | globenewswire.comGSK has application to expand use of mepolizumab accepted by EMAMarch 24 at 10:51 AM | lse.co.ukGSK's Omjjara (momelotinib) approved in Singapore as the first treatment indicated for myelofibrosis patients with anaemiaMarch 24 at 10:51 AM | finance.yahoo.comEuropean regulators to review GSK's asthma drug Nucala to treat COPDMarch 24 at 10:51 AM | msn.comClass Action Filed Against GSK plc (GSK) - April 7, 2025 Deadline to Join - Contact The Gross Law FirmMarch 24 at 5:45 AM | prnewswire.comQuantbot Technologies LP Has $3.02 Million Stock Holdings in GSK plc (NYSE:GSK)Quantbot Technologies LP cut its position in shares of GSK plc (NYSE:GSK - Free Report) by 57.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 89,371 shares of the pharmaceutical comMarch 24 at 5:17 AM | marketbeat.comGSK says European regulator reviewing expanded use of asthma drug NucalaMarch 24 at 3:26 AM | reuters.comGSK Investors Have Opportunity to Lead GSK plc Securities Fraud LawsuitMarch 23 at 10:26 AM | gurufocus.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSKMarch 23 at 9:17 AM | globenewswire.comGSK Investors Have Opportunity to Lead GSK plc Securities Fraud LawsuitMarch 23 at 9:00 AM | prnewswire.comWhittier Trust Co. Acquires 21,826 Shares of GSK plc (NYSE:GSK)Whittier Trust Co. raised its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 133.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 38,150 shares of the pharmaceutical company's stock after acquiring an additional 21,826 shares during the period.March 23 at 5:15 AM | marketbeat.comGSK plc (NYSE:GSK) Stock Holdings Trimmed by Envestnet Portfolio Solutions Inc.Envestnet Portfolio Solutions Inc. trimmed its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 13.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 45,017 shares of the pharmaceutical company's stock after selling 7,125 shares during tMarch 23 at 4:01 AM | marketbeat.comGSK plc (NYSE:GSK) Stock Holdings Lifted by Corient Private Wealth LLCCorient Private Wealth LLC lifted its holdings in GSK plc (NYSE:GSK - Free Report) by 12.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 96,344 shares of the pharmaceutical company's stock after buying an additional 10,895 shares duringMarch 23 at 3:44 AM | marketbeat.comGSK plc (NYSE:GSK) Receives Average Recommendation of "Moderate Buy" from BrokeragesGSK plc (NYSE:GSK - Get Free Report) has received an average rating of "Moderate Buy" from the ten ratings firms that are currently covering the stock, Marketbeat.com reports. Seven investment analysts have rated the stock with a hold recommendation and three have issued a strong buy recommendatioMarch 23 at 2:35 AM | marketbeat.comROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSKMarch 22 at 9:58 AM | investing.comAdvisors Asset Management Inc. Decreases Stake in GSK plc (NYSE:GSK)Advisors Asset Management Inc. reduced its position in shares of GSK plc (NYSE:GSK - Free Report) by 10.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 127,651 shares of the pharmaceutical company's stock afteMarch 22 at 4:36 AM | marketbeat.comInvestors who lost money on GSK plc(GSK) should contact Levi & Korsinsky about pending Class Action - GSKMarch 21, 2025 | globenewswire.comROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSKMarch 21, 2025 | globenewswire.comGSK Board Members Increase Stake in CompanyMarch 21, 2025 | tipranks.comGSK LAWSUIT ALERT: Levi & Korsinsky Notifies GSK plc Investors of a Class Action Lawsuit ...March 21, 2025 | gurufocus.comGSK LAWSUIT ALERT: Levi & Korsinsky Notifies GSK plc Investors of a Class Action Lawsuit and Upcoming DeadlineMarch 21, 2025 | prnewswire.comTocqueville Asset Management L.P. Acquires 8,950 Shares of GSK plc (NYSE:GSK)Tocqueville Asset Management L.P. boosted its holdings in GSK plc (NYSE:GSK - Free Report) by 23.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 46,900 shares of the pharmaceutical company's stock after purchasing anMarch 21, 2025 | marketbeat.comROSEN, A LEADING NATIONAL FIRM, Encourages GSK plc Investors to Secure Counsel Before Important ...March 20, 2025 | gurufocus.comROSEN, A LEADING NATIONAL FIRM, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSKMarch 20, 2025 | globenewswire.comThe Gross Law Firm Reminds GSK plc Investors of the Pending Class Action Lawsuit with a Lead ...March 20, 2025 | gurufocus.comThe Gross Law Firm Reminds GSK plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 – GSKMarch 20, 2025 | globenewswire.comGSK (NYSE:GSK) Shares Gap Down - Here's WhyGSK (NYSE:GSK) Shares Gap Down - Time to Sell?March 20, 2025 | marketbeat.comGSK plc Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April ...March 20, 2025 | gurufocus.comProVise Management Group LLC Sells 11,304 Shares of GSK plc (NYSE:GSK)ProVise Management Group LLC cut its holdings in GSK plc (NYSE:GSK - Free Report) by 9.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 112,051 shares of the pharmaceutical company's stock after selling 11,304 shares dMarch 20, 2025 | marketbeat.comGSK plc Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - GSKMarch 20, 2025 | prnewswire.comNatixis Advisors LLC Sells 157,161 Shares of GSK plc (NYSE:GSK)Natixis Advisors LLC lowered its position in GSK plc (NYSE:GSK - Free Report) by 31.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 343,334 shares of the pharmaceutical company's stock after selling 157,16March 20, 2025 | marketbeat.comStocks to Watch Wednesday: Tesla, Nvidia, Gilead, GSKMarch 19, 2025 | wsj.comWhy GSK plc (GSK) Is Among the Most Undervalued Biotech Stocks to Invest InMarch 19, 2025 | msn.comGSK plc. (GSK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitMarch 19, 2025 | gurufocus.comGSK plc. (GSK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitMarch 19, 2025 | prnewswire.comSignaturefd LLC Increases Stock Position in GSK plc (NYSE:GSK)Signaturefd LLC lifted its holdings in GSK plc (NYSE:GSK - Free Report) by 25.1% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 40,090 shares of the pharmaceutical company's stock after purchasing an additional 8,035 shares during the period. Signaturefd LLC'sMarch 19, 2025 | marketbeat.comGSK plc (NYSE:GSK) Shares Sold by Commonwealth Equity Services LLCCommonwealth Equity Services LLC lessened its stake in shares of GSK plc (NYSE:GSK - Free Report) by 1.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 348,385 shares of the pharmaceutical company's stock after selling 6,718 shares duMarch 19, 2025 | marketbeat.comShort Interest in GSK plc (NYSE:GSK) Rises By 31.7%March 19, 2025 | americanbankingnews.com Remove Ads Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address GSK Media Mentions By Week GSK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼0.310.62▲Average Medical News Sentiment GSK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼5315▲GSK Articles Average Week Remove Ads Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AstraZeneca News Today Novartis News Today Sanofi News Today Takeda Pharmaceutical News Today argenx News Today Beigene News Today BioNTech News Today Teva Pharmaceutical Industries News Today Summit Therapeutics News Today Intra-Cellular Therapies News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:GSK) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GSK Stock Free GSK Stock Alerts